Indoco Remedies Ltd. : Q4FY17 Results
Amir Shaikh / 26 May 2017
Total sales for this quarter, Q3FY17, came in at Rs. 276.9 crore. This represents a 0.32 per cent sequential decline and 4.42 per cent YoY increase.
Indoco Remedies Ltd. reported its results for the quarter ended March 31, 2017.
Total sales for this quarter, Q3FY17, came in at Rs. 276.9 crore. This represents a 0.32 per cent sequential decline and 4.42 per cent YoY increase.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 17.2 crore and the EBIT margin stood at 6.2 per cent.
In terms of the bottom-line, the company reported a PAT figure of Rs. 17.9 crore which represents a sequential QoQ increase of 1.99 per cent and a YoY decline of 14.37 per cent.
The company's stock opened on a flat note, hit intraday high and low of Rs 198.75 and Rs 188.70 respectively and is currently trading at Rs 190.5 with 0.76% decline.
Indoco Remedies Ltd is an Indian company engaged in the business of manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in India.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.